Dexcom | Des Atouts



Assets Changement Date
Abbott USD 81.45B 34M 2025-03
Align Technology USD 6.1B 111.78M 2025-03
AtriCure USD 591.63M 17.7M 2025-03
Avanos Medical USD 1.15B 502M 2024-12
Baxter International USD 25.78B 894M 2024-12
Becton, Dickinson and Co. USD 54.67B 2.62B 2024-12
Boston Scientific USD 39.4B 1.32B 2024-12
Cooper Companies USD 12.22B 93M 2025-01
Dexcom USD 6.48B 130.7M 2024-12
Edwards Lifesciences USD 13.06B 84.1M 2024-12
Globus Medical USD 5.25B 165.71M 2024-12
Hologic USD 8.73B 427.3M 2024-12
Insulet USD 3.09B 62.3M 2024-12
Integra LifeSciences USD 4.04B 28.38M 2024-12
J&J USD 193.67B 13.57B 2025-03
Masimo USD 2.63B 462.1M 2024-12
Medtronic USD 89.97B 69M 2025-01
Merit Medical Systems USD 2.47B 49.37M 2025-03
Roche Holding CHF 101.8B 6.02B 2024-12
Solventum Corp 14.46B 288M 2024-12
Stryker USD 42.97B 862M 2024-12
Tandem Diabetes Care USD 922.14M 45.52M 2025-03
Teleflex USD 7.16B 65.38M 2025-03
West Pharmaceutical Services USD 3.62B 25.2M 2025-03
Zimmer Biomet Holdings USD 21.37B 355M 2024-12



Dexcom Des Atouts - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2025.